The signal transduction pathways modulating bFGF effects in renal tubular e
pithelial cells (RTEc) are not completely understood. Since the cAMP and th
e mitogen-activated protein kinase (MAPK) pathways can modulate the growth
of RTEc, we studied whether two cAMP elevating agents, isoproterenol and 8-
bromo-cAMP, would modulate basic fibroblast growth factor (bFGF) induction
of MAPK activity (ERK-2) and cell proliferation in human renal proximal tub
ular epithelial cells (RPTEc) and Madin-Darby canine kidney cells (MDCK clo
ne (E11)). Isoproterenol, but not bFGF, stimulated cAMP production in RPTEc
and MDCKE11 cells. bFGF, isoproterenol, and 8-bromo-cAMP alone increased E
RK-2 activity in both cell types. However, isoproterenol and 8-bromo-cAMP p
artially inhibited the bFGF induction of ERK-2 activity, but only isoproter
enol inhibited the proliferation of both cell types. PD098059 (25 mu M). an
inhibitor of MAPK kinase (MEK 1/2). blocked the bFGF mitogenic effects, bu
t did not affect the 8-bromo-cAMP-induced mitogenic effects in MDCKE11 cell
s. These findings suggest that activation of ERK-2 is required but not suff
icient for mitogenesis in RTEc. We conclude that isoproterenol inhibits the
growth-promoting effects of bFGF in RTEc via MEK-dependent and -independen
t pathways.